Literature DB >> 11809434

Impact of troglitazone on coronary stent implantation using small stents in patients with type 2 diabetes mellitus.

Tsutomu Takagi1, Atsushi Yamamuro, Koichi Tamita, Kenji Yamabe, Minako Katayama, Shigefumi Morioka, Takashi Akasaka, Kiyoshi Yoshida.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11809434     DOI： 10.1016/s0002-9149(01)02232-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

Review 1.  Cardiovascular Risk in Diabetes Mellitus: Complication of the Disease or of Antihyperglycemic Medications.

Authors:  C A Alvarez; I Lingvay; V Vuylsteke; R L Koffarnus; D K McGuire
Journal:  Clin Pharmacol Ther       Date:  2015-07-03       Impact factor: 6.875

Review 2.  Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.

Authors:  Annaswamy Raji; Jorge Plutzky
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 3.  Metabolic syndrome therapy: prevention of vascular injury by antidiabetic agents.

Authors:  Ligia J Dominguez; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

4.  Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?

Authors:  Sayeeda Rahman; Aziz Al-Shafi Ismail; Abdul Rashid A Rahman
Journal:  Int J Diabetes Dev Ctries       Date:  2009-07

Review 5.  Reduction of cardiovascular morbidity and mortality in type 2 diabetes. A rational approach to hypoglycemic therapy.

Authors:  P Spallarossa; A Barsotti; R Cordera; G Ghigliotti; D Maggi; C Brunelli
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 6.  Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Authors:  Marc Evans; Aled Roberts; Steve Davies; Alan Rees
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 7.  The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus.

Authors:  Chris P H Lexis; Braim M Rahel; Joan G Meeder; Felix Zijlstra; Iwan C C van der Horst
Journal:  Cardiovasc Diabetol       Date:  2009-07-28       Impact factor: 9.951

8.  Transcriptional Control of Vascular Smooth Muscle Cell Proliferation by Peroxisome Proliferator-Activated Receptor-gamma: Therapeutic Implications for Cardiovascular Diseases.

Authors:  Florence Gizard; Dennis Bruemmer
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

9.  Effects of low dose pioglitazone on restenosis and coronary atherosclerosis in diabetic patients undergoing drug eluting stent implantation.

Authors:  Hye Won Lee; Han Cheol Lee; Bo Won Kim; Mi Jin Yang; Jin Sup Park; Jun Hyok Oh; Jung Hyun Choi; Kwang Soo Cha; Taek Jong Hong; Sang-Pil Kim; Seunghwan Song; Jong-Ha Park
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.